Suchbegriffe: OLIGODENDROGLIA - PATHOLOGY , . Treffer: 5
Höftberger, R; Guo, Y; Flanagan, EP; Lopez-Chiriboga, AS; Endmayr, V; Hochmeister, S; Joldic, D; Pittock, SJ; Tillema, JM; Gorman, M; Lassmann, H; Lucchinetti, CF
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody.
Acta Neuropathol. 2020; 139(5):875-892
Doi: 10.1007/s00401-020-02132-y
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Asslaber, M; Schauer, S; Gogg-Kamerer, M; Bernhart, E; Quehenberger, F; Haybaeck, J
Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
J Neuropathol Exp Neurol. 2017; 76(1):16-26
Doi: 10.1093/jnen/nlw098
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lebrun-Julien, F; Bachmann, L; Norrmén, C; Trötzmüller, M; Köfeler, H; Rüegg, MA; Hall, MN; Suter, U
Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.
J NEUROSCI. 2014; 34(25): 8432-8448.
Doi: 10.1523/JNEUROSCI.1105-14.2014
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Henneke, M; Combes, P; Diekmann, S; Bertini, E; Brockmann, K; Burlina, AP; Kaiser, J; Ohlenbusch, A; Plecko, B; Rodriguez, D; Boespflug-Tanguy, O; Gärtner, J
GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
Neurology. 2008; 70(10):748-754
Doi: 10.1212/01.wnl.0000284828.84464.35
Web of Science
PubMed
FullText
FullText_MUG
Storch, MK; Piddlesden, S; Haltia, M; Iivanainen, M; Morgan, P; Lassmann, H
Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Ann Neurol. 1998; 43(4):465-471
Doi: 10.1002/ana.410430409
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG